H1 Mobile to offer latest information and research in multiple fields.
H1 has officially launched the H1 mobile app. Designed to support life sciences teams and help medical science liaisons (MSLs) remain informed of the latest information and research in their respective fields, the mobile app reportedly brings deep key opinion leader (KOL) and healthcare professional (HCP) insights to the palms of life sciences professionals worldwide.
According to a company press release, the app provides MSLs the ability to:
“We believe that knowledge is power, and our new mobile app puts that power directly in the hands of MSLs wherever they are,” said Ariel Katz, CEO, H1. “Expertise and knowledge are the currency of an MSL, and it is crucial to provide them with the right resources to make every interaction with a KOL impactful. Thousands of life sciences professionals access our insights on a daily basis. Now they can not only tap into the same data and insights via their mobile devices, but they can set up proactive notifications to ensure they are seeing the latest updates related to the KOLs and HCPs they care about in real-time.”
Reference: H1 Launches H1 Mobile App to Empower Medical Affairs with Real-Time KOL Insights and Expertise on the Go. GlobeNewswire. August 14, 2023. Accessed August 14, 2023. https://www.globenewswire.com/news-release/2023/08/14/2724543/0/en/H1-Launches-H1-Mobile-App-to-Empower-Medical-Affairs-with-Real-Time-KOL-Insights-and-Expertise-on-the-Go.html
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.